Paxil Birth Defect Plaintiff Dismissed Case 1 Day Before GSK's Removal, Judge Finds

Paxil Birth Defect Plaintiff Dismissed Case 1 Day Before GSK's Removal, Judge Finds

PHILADELPHIA - A Pennsylvania federal judge on Sept. 19 remanded a Paxil birth defect case after finding that the plaintiff properly dismissed her state court case one day before defendant SmithKline Beecham Corp. (now GlaxoSmithKline PLC $(GSK$)) removed it to federal court on the basis of diversity jurisdiction (Jade Benge, et al. v. SmithKline Beecham Corporation, et al., No. 13-3388, E.D. Pa.).

Find full version on lexis Advance®
Access this news story on lexis.com®